Note 21 - Financial Information About the Parent, the Issuer and the Guarantors (Detail) - Condensed Consolidating Statement Of Cash Flows (USD $)
|
12 Months Ended |
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2010
|
Net cash provided by (used in) operating activities |
$ 37,701,000
|
$ 63,162,000
|
$ 51,331,000
|
Cash flows from investing activities: |
|
|
|
Capital expenditures |
22,884,000
|
9,094,000
|
9,922,000
|
Acquisitions |
520,000
|
2,957,000
|
50,000
|
Proceeds from the disposal of property, plant and equipment |
1,873,000
|
3,196,000
|
13,198,000
|
Change in restricted cash and investments |
(975,000)
|
(927,000)
|
17,318,000
|
Purchase of marketable securities |
3,647,000
|
9,466,000
|
11,364,000
|
Proceeds from the sale of marketable securities |
7,230,000
|
7,319,000
|
200,000
|
Other |
(816,000)
|
(432,000)
|
(165,000)
|
Net cash provided by (used in) investing activities |
(16,157,000)
|
(9,643,000)
|
(25,091,000)
|
Payments on long-term debt |
12,204,000
|
37,887,000
|
42,000
|
Purchases and other retirements of company stock |
1,350,000
|
5,377,000
|
|
Dividends paid |
8,062,000
|
5,754,000
|
5,801,000
|
Net cash provided by (used in) financing activities |
(20,878,000)
|
(49,079,000)
|
(6,041,000)
|
Effect of exchange rate changes on cash |
536,000
|
227,000
|
693,000
|
Net decrease in cash and cash equivalents |
1,202,000
|
4,667,000
|
20,892,000
|
Cash & cash equivalents - beginning of year |
78,519,000
|
73,852,000
|
52,960,000
|
Cash & cash equivalents - end of year |
79,721,000
|
78,519,000
|
73,852,000
|
Parent Company [Member]
|
|
|
|
Net cash provided by (used in) operating activities |
9,187,000
|
11,055,000
|
5,800,000
|
Cash flows from investing activities: |
|
|
|
Purchases and other retirements of company stock |
(1,350,000)
|
(5,377,000)
|
|
Proceeds from issuance of common stock |
225,000
|
76,000
|
1,000
|
Dividends paid |
(8,062,000)
|
(5,754,000)
|
(5,801,000)
|
Net cash provided by (used in) financing activities |
(9,187,000)
|
(11,055,000)
|
(5,800,000)
|
Subsidiary Issuer [Member]
|
|
|
|
Net cash provided by (used in) operating activities |
3,939,000
|
38,590,000
|
48,466,000
|
Cash flows from financing activities: |
|
|
|
Increase in deferred financing costs |
|
(137,000)
|
(199,000)
|
Cash flows from investing activities: |
|
|
|
Capital expenditures |
(1,952,000)
|
(1,182,000)
|
(393,000)
|
Proceeds from the disposal of property, plant and equipment |
12,000
|
|
|
Change in restricted cash and investments |
975,000
|
927,000
|
(17,318,000)
|
Purchase of marketable securities |
(3,647,000)
|
(9,466,000)
|
(11,364,000)
|
Proceeds from the sale of marketable securities |
7,230,000
|
7,319,000
|
200,000
|
Other |
305,000
|
432,000
|
165,000
|
Net cash provided by (used in) investing activities |
2,923,000
|
(1,970,000)
|
(28,710,000)
|
Payments on long-term debt |
(11,917,000)
|
(33,989,000)
|
|
Excess tax benefits from share-based payment arrangements |
238,000
|
|
|
Net cash provided by (used in) financing activities |
(11,679,000)
|
(34,126,000)
|
(199,000)
|
Net decrease in cash and cash equivalents |
(4,817,000)
|
2,494,000
|
19,557,000
|
Cash & cash equivalents - beginning of year |
69,763,000
|
67,269,000
|
47,712,000
|
Cash & cash equivalents - end of year |
64,946,000
|
69,763,000
|
67,269,000
|
Guarantor Subsidiaries [Member]
|
|
|
|
Net cash provided by (used in) operating activities |
18,441,000
|
10,672,000
|
(4,272,000)
|
Cash flows from investing activities: |
|
|
|
Capital expenditures |
(15,721,000)
|
(5,017,000)
|
(6,706,000)
|
Acquisitions |
(520,000)
|
(2,957,000)
|
(50,000)
|
Proceeds from the disposal of property, plant and equipment |
1,861,000
|
3,196,000
|
13,198,000
|
Other |
511,000
|
|
|
Net cash provided by (used in) investing activities |
(13,869,000)
|
(4,778,000)
|
6,442,000
|
Payments on long-term debt |
(287,000)
|
(3,898,000)
|
(42,000)
|
Proceeds from noncontrolling interest |
275,000
|
|
|
Net cash provided by (used in) financing activities |
(12,000)
|
(3,898,000)
|
(42,000)
|
Net decrease in cash and cash equivalents |
4,560,000
|
1,996,000
|
2,128,000
|
Cash & cash equivalents - beginning of year |
7,716,000
|
5,720,000
|
3,592,000
|
Cash & cash equivalents - end of year |
12,276,000
|
7,716,000
|
5,720,000
|
Non-Guarantor Subsidiaries [Member]
|
|
|
|
Net cash provided by (used in) operating activities |
6,134,000
|
2,845,000
|
1,337,000
|
Cash flows from investing activities: |
|
|
|
Capital expenditures |
(5,211,000)
|
(2,895,000)
|
(2,823,000)
|
Net cash provided by (used in) investing activities |
(5,211,000)
|
(2,895,000)
|
(2,823,000)
|
Effect of exchange rate changes on cash |
536,000
|
227,000
|
693,000
|
Net decrease in cash and cash equivalents |
1,459,000
|
177,000
|
(793,000)
|
Cash & cash equivalents - beginning of year |
1,040,000
|
863,000
|
1,656,000
|
Cash & cash equivalents - end of year |
2,499,000
|
1,040,000
|
863,000
|
Consolidated Entities [Member]
|
|
|
|
Net cash provided by (used in) operating activities |
37,701,000
|
63,162,000
|
51,331,000
|
Cash flows from financing activities: |
|
|
|
Increase in deferred financing costs |
|
(137,000)
|
(199,000)
|
Cash flows from investing activities: |
|
|
|
Capital expenditures |
(22,884,000)
|
(9,094,000)
|
(9,922,000)
|
Acquisitions |
(520,000)
|
(2,957,000)
|
(50,000)
|
Proceeds from the disposal of property, plant and equipment |
1,873,000
|
3,196,000
|
13,198,000
|
Change in restricted cash and investments |
975,000
|
927,000
|
(17,318,000)
|
Purchase of marketable securities |
(3,647,000)
|
(9,466,000)
|
(11,364,000)
|
Proceeds from the sale of marketable securities |
7,230,000
|
7,319,000
|
200,000
|
Other |
816,000
|
432,000
|
165,000
|
Net cash provided by (used in) investing activities |
(16,157,000)
|
(9,643,000)
|
(25,091,000)
|
Payments on long-term debt |
(12,204,000)
|
(37,887,000)
|
(42,000)
|
Purchases and other retirements of company stock |
(1,350,000)
|
(5,377,000)
|
|
Proceeds from issuance of common stock |
225,000
|
76,000
|
1,000
|
Excess tax benefits from share-based payment arrangements |
238,000
|
|
|
Proceeds from noncontrolling interest |
275,000
|
|
|
Dividends paid |
(8,062,000)
|
(5,754,000)
|
(5,801,000)
|
Net cash provided by (used in) financing activities |
(20,878,000)
|
(49,079,000)
|
(6,041,000)
|
Effect of exchange rate changes on cash |
536,000
|
227,000
|
693,000
|
Net decrease in cash and cash equivalents |
1,202,000
|
4,667,000
|
20,892,000
|
Cash & cash equivalents - beginning of year |
78,519,000
|
73,852,000
|
52,960,000
|
Cash & cash equivalents - end of year |
$ 79,721,000
|
$ 78,519,000
|
$ 73,852,000
|